| scholarly article | Q13442814 |
| P50 | author | Bertrand Godeau | Q64337424 |
| P2093 | author name string | Marc Michel | |
| Mehdi Khellaf | |||
| Philippe Bierling | |||
| Carole Pierrot-Deseilligny Despujol | |||
| Liliane Intrator | |||
| Michèle Gouault | |||
| P2860 | cites work | International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) | Q28292418 |
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study | Q33338827 | ||
| Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients | Q33341941 | ||
| Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy | Q33346561 | ||
| Antiphospholipid antibodies in immune thrombocytopenic purpura tend to emerge in exacerbation and decline in remission | Q33364647 | ||
| The association of thrombocytopenia with systemic manifestations in the antiphospholipid syndrome | Q33369426 | ||
| Antiphospholipid antibodies (APLA) in immune thrombocytopenic purpura (ITP) and antiphospholipid syndrome (APS). | Q33371129 | ||
| Anticardiolipin antibodies in autoimmune thrombocytopenic purpura | Q33459994 | ||
| Long-term observation of 208 adults with chronic idiopathic thrombocytopenic purpura. | Q33489560 | ||
| International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop | Q33685960 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | thrombocytopenia | Q585285 |
| Immune thrombocytopenic purpura | Q3410984 | ||
| P304 | page(s) | 638-643 | |
| P577 | publication date | 2008-05-28 | |
| P1433 | published in | British Journal of Haematology | Q4970200 |
| P1476 | title | Antiphospholipid antibodies in adults with immune thrombocytopenic purpura | |
| P478 | volume | 142 |
| Q38656360 | ANMCO Position Paper: long-term follow-up of patients with pulmonary thromboembolism. |
| Q92314364 | Advances in the Research on Anticardiolipin Antibody |
| Q38039441 | Autoimmune diseases and venous thromboembolism: a review of the literature. |
| Q85238648 | Blind men and the APS |
| Q58585814 | Chronic Thromboembolic Pulmonary Hypertension and Antiphospholipid Syndrome with Immune Thrombocytopenia: A Case Report |
| Q33398955 | Clinical implications of elevated antiphospholipid antibodies in adult patients with primary immune thrombocytopenia |
| Q33425644 | Efficacy and safety of the thrombopoietin receptor agonist romiplostim in patients aged ≥ 65 years with immune thrombocytopenia |
| Q90602246 | Guideline on immune thrombocytopenia in adults: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Project guidelines: Associação Médica Brasileira - 2018 |
| Q38856073 | IgG/IgM antiphospholipid antibodies present in the classification criteria for the antiphospholipid syndrome: a critical review of their association with thrombosis |
| Q33431417 | Incidence of Antiphospholipid Antibodies in Patients With Immune Thrombocytopenia and Correlation With Treatment With Steroids in North Indian Population |
| Q33436927 | Lupus anticoagulant hypoprothrombinemia syndrome associated with severe thrombocytopenia in a child |
| Q33401971 | Management of myocardial infarction in immune thrombocytopenic purpura with anti-phospholipid antibodies |
| Q33386861 | New therapeutic agents in immunologic idiopathic thrombocytopenic purpura treatment: thrombopoietin receptor agonists |
| Q33383894 | New-generation drugs that stimulate platelet production in chronic immune thrombocytopenic purpura |
| Q33382856 | Nitric oxide in immune thrombocytopenic purpura |
| Q37812011 | Primary Thrombosis Prophylaxis in Antiphospholipid Antibody–Positive Patients: Where Do We Stand? |
| Q33436189 | Procoagulant profile in patients with immune thrombocytopenia. |
| Q33400125 | Relationship between some clinical situations, autoantibodies, and pseudothrombocytopenia |
| Q33394044 | Task Force on Catastrophic Antiphospholipid Syndrome (APS) and Non-criteria APS Manifestations (II): thrombocytopenia and skin manifestations |
| Q33420910 | The significance and management of thrombocytopenia in antiphospholipid syndrome |
| Q33434497 | Thrombocytopenic syndromes in pregnancy |
| Q30250259 | Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis |
| Q33431551 | Thromboembolism in patients with immune thrombocytopenia (ITP): a meta-analysis of observational studies |
| Q33406643 | Thrombotic risk in patients with immune thrombocytopenia and its association with antiphospholipid antibodies |
| Q33415996 | Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors. |
Search more.